Arkolith/Insider Trading/ATAI/Form 4

Apeiron Investment Group Ltd.

10% OwnerATAI Life Sciences N.V. (ATAI) · full profile →Form 4 · filed Oct 2, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 30, 2025Conversion(C)2.4M——53.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 30, 2025Conversion(C)148K——0

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-228361) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML